Cargando…

Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations

OBJECTIVE: Gender-affirming hormones (GAH)—the use of sex hormones to induce desired secondary sex characteristics in transgender individuals—is vital healthcare for many transgender people. Among prescribers of GAH, there is debate regarding the value of a universal requirement for an evaluation by...

Descripción completa

Detalles Bibliográficos
Autores principales: Stroumsa, Daphna, Minadeo, Leah A., Maksutova, Mariam, Moravek, Molly B., Stephenson, Rob, Pfeiffer, Paul N., Wu, Justine P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387802/
https://www.ncbi.nlm.nih.gov/pubmed/35980962
http://dx.doi.org/10.1371/journal.pone.0271785
_version_ 1784770081982513152
author Stroumsa, Daphna
Minadeo, Leah A.
Maksutova, Mariam
Moravek, Molly B.
Stephenson, Rob
Pfeiffer, Paul N.
Wu, Justine P.
author_facet Stroumsa, Daphna
Minadeo, Leah A.
Maksutova, Mariam
Moravek, Molly B.
Stephenson, Rob
Pfeiffer, Paul N.
Wu, Justine P.
author_sort Stroumsa, Daphna
collection PubMed
description OBJECTIVE: Gender-affirming hormones (GAH)—the use of sex hormones to induce desired secondary sex characteristics in transgender individuals—is vital healthcare for many transgender people. Among prescribers of GAH, there is debate regarding the value of a universal requirement for an evaluation by a mental health provider prior to GAH initiation. The purpose of this qualitative study was to describe the range of attitudes and approaches to mental health evaluation among GAH providers in the United States. We analyzed the providers’ attitudes and base our recommendations on this analysis. METHODS: We conducted semi-structured interviews with 18 healthcare providers who prescribe GAH across the United States. Participants were purposefully recruited using professional networks and snowball sampling to include those who require mental health evaluation and those who do not. We adapted domains from the Theoretical Domains Framework—a framework for understanding influences on health professional behavior—to inform the interviews and analysis. Guided by these domains, we iteratively coded text and identified theoretical relationships among the categories. RESULTS: While some felt a universal requirement for mental health “clearance” was necessary for the identification of appropriate candidates for GAH, others described this requirement as a form of “gatekeeping” that limits access to care. Themes we identified included providers’ ability to ascertain gender identity; concern about mental illness; GAH provider and mental health provider expertise; and provider roles. All providers appreciated the potential advantages of mental health support during GAH treatment. CONCLUSION: Providers in our study practice on a continuum of care rather than adhering to strict rules about the requirement for mental health evaluation prior to GAH treatment. Where they fall on this continuum is influenced primarily by their perceptions of transgender identity and transition, and their interpretation of risk for significant mental illness and its association with transness. Providers who required universal evaluation by a mental health professional tended to hold essentialist, medicalized, and binary ideas of gender and transness.
format Online
Article
Text
id pubmed-9387802
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-93878022022-08-19 Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations Stroumsa, Daphna Minadeo, Leah A. Maksutova, Mariam Moravek, Molly B. Stephenson, Rob Pfeiffer, Paul N. Wu, Justine P. PLoS One Research Article OBJECTIVE: Gender-affirming hormones (GAH)—the use of sex hormones to induce desired secondary sex characteristics in transgender individuals—is vital healthcare for many transgender people. Among prescribers of GAH, there is debate regarding the value of a universal requirement for an evaluation by a mental health provider prior to GAH initiation. The purpose of this qualitative study was to describe the range of attitudes and approaches to mental health evaluation among GAH providers in the United States. We analyzed the providers’ attitudes and base our recommendations on this analysis. METHODS: We conducted semi-structured interviews with 18 healthcare providers who prescribe GAH across the United States. Participants were purposefully recruited using professional networks and snowball sampling to include those who require mental health evaluation and those who do not. We adapted domains from the Theoretical Domains Framework—a framework for understanding influences on health professional behavior—to inform the interviews and analysis. Guided by these domains, we iteratively coded text and identified theoretical relationships among the categories. RESULTS: While some felt a universal requirement for mental health “clearance” was necessary for the identification of appropriate candidates for GAH, others described this requirement as a form of “gatekeeping” that limits access to care. Themes we identified included providers’ ability to ascertain gender identity; concern about mental illness; GAH provider and mental health provider expertise; and provider roles. All providers appreciated the potential advantages of mental health support during GAH treatment. CONCLUSION: Providers in our study practice on a continuum of care rather than adhering to strict rules about the requirement for mental health evaluation prior to GAH treatment. Where they fall on this continuum is influenced primarily by their perceptions of transgender identity and transition, and their interpretation of risk for significant mental illness and its association with transness. Providers who required universal evaluation by a mental health professional tended to hold essentialist, medicalized, and binary ideas of gender and transness. Public Library of Science 2022-08-18 /pmc/articles/PMC9387802/ /pubmed/35980962 http://dx.doi.org/10.1371/journal.pone.0271785 Text en © 2022 Stroumsa et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Stroumsa, Daphna
Minadeo, Leah A.
Maksutova, Mariam
Moravek, Molly B.
Stephenson, Rob
Pfeiffer, Paul N.
Wu, Justine P.
Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations
title Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations
title_full Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations
title_fullStr Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations
title_full_unstemmed Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations
title_short Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers’ perspectives on requiring mental health evaluations
title_sort initiating gender-affirming hormones for transgender and non-binary people: a qualitative study of providers’ perspectives on requiring mental health evaluations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387802/
https://www.ncbi.nlm.nih.gov/pubmed/35980962
http://dx.doi.org/10.1371/journal.pone.0271785
work_keys_str_mv AT stroumsadaphna initiatinggenderaffirminghormonesfortransgenderandnonbinarypeopleaqualitativestudyofprovidersperspectivesonrequiringmentalhealthevaluations
AT minadeoleaha initiatinggenderaffirminghormonesfortransgenderandnonbinarypeopleaqualitativestudyofprovidersperspectivesonrequiringmentalhealthevaluations
AT maksutovamariam initiatinggenderaffirminghormonesfortransgenderandnonbinarypeopleaqualitativestudyofprovidersperspectivesonrequiringmentalhealthevaluations
AT moravekmollyb initiatinggenderaffirminghormonesfortransgenderandnonbinarypeopleaqualitativestudyofprovidersperspectivesonrequiringmentalhealthevaluations
AT stephensonrob initiatinggenderaffirminghormonesfortransgenderandnonbinarypeopleaqualitativestudyofprovidersperspectivesonrequiringmentalhealthevaluations
AT pfeifferpauln initiatinggenderaffirminghormonesfortransgenderandnonbinarypeopleaqualitativestudyofprovidersperspectivesonrequiringmentalhealthevaluations
AT wujustinep initiatinggenderaffirminghormonesfortransgenderandnonbinarypeopleaqualitativestudyofprovidersperspectivesonrequiringmentalhealthevaluations